Comparison of [18F]altanserin and [18F]deuteroaltanserin for PET imaging of serotonin2A receptors in baboon brain: Pharmacological studies

Nuclear Medicine and Biology

Volumn 28, Issue 3, 2001, Pages 271-279

  Staley, Julie K ^a   Van Dyck, Christopher H ^a   Tan, Ping Zhong ^a   Al Tikriti, Mohammed ^a   Ramsby, Quinn ^a   Klump, Heide ^a   Ng, Chin ^a   Garg, Pradeep ^a   Soufer, Robert ^a   Baldwin, Ronald M ^a   Innis, Robert B ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 HT2A receptor; PET; Primate brain; Serotonin

Indexed keywords

ALTANSERIN F 18; DEUTEROALTANSERIN F 18; EPLIVANSERIN; FENFLURAMINE; KETANSERIN; SEROTONIN; SEROTONIN 2A RECEPTOR; TRACER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BABOON; BOLUS INJECTION; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG DISTRIBUTION; DRUG SPECIFICITY; FEMALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN; DEUTERIUM; FEMALE; FLUORINE RADIOISOTOPES; KETANSERIN; PAPIO; RADIOCHEMISTRY; RECEPTORS, SEROTONIN; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0035059946     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(00)00212-2     Document Type: Article

References (44)

1. 18F]altanserinol
2. A review of central 5-HT receptors and their function
3. 2 receptors in humans using positron emission tomography
4. 18F]Setoperone: A new high-affinity ligand for positron emission tomography study of the serotonin-2 receptors in baboon brain in vivo
5. 2C receptors
6. 2A receptor mRNA in human brain
7. 18F]fluoroethyl)spiperone in baboon brain
8. Ketanserin binds to the monoamine transporter of chromaffin granules and of synaptic vesicles
9. 2A receptor mRNA in human postmortem brain using competitive RT-PCR
10. Spatial registration and normalisation of images
11. Mechanisms of effects of d-fenfluramine on brain serotonin in rats: Uptake inhibition versus release
12. Biochemical pharmacology of the anorectic drug fenfluramine: A review
13. 1 recognition sites
14. Imaging receptor occupancy by endogenous transmitters in humans
15. Fluorine-18-Altanserin: A radioligand for the study of serotonin receptors with PET: Radiolabeling and in vivo biologic behavior in rats
16. Use of 5-HT receptor agonists and antagonists for the characterization of their respective receptor sites
17. 2 receptors
18. 3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs
19. 2 receptor binding sites. Binding properties, brain distribution, and functional role
20. 18F]altanserin: Implications for kinetic modeling
21. 2 receptors in human brain
22. Anorectic effect of fenfluramine isomers and metabolites: Relationship between brain levels and in vitro potencies on serotonergic mechanisms
23. Comparative anatomical distribution of serotonin 1A, 1D alpha and 2A receptor mRNAs in human brain
24. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors
25. Accurate three-dimensional registration of CT, PET, and/or MR image of the brain
26. 5-Hydroxytryptamine receptors
27. 18F]Altanserin PET studies of serotonin-2A binding: Examination of nonspecific component
28. Comparative penetration of glycopyrrolate and atropine across the blood-brain and placental barriers in anesthetized dogs
29. Anatomical atlas of the baboon's brain in the orbito-meatal plane used in experimental positron emission tomography
30. Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hyrdroxytryptamine2 receptor antagonist
31. 2 receptor antagonist, in rodent brain
32. 2C): Where structure meets function
33. Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates: Implications for primary pulmonary hypertension
34. 18F]altanserin: Results in young normal controls
35. 77Br
36. Effects of fluoxetine or D-fenfluramine on serotonin release from, and levels in, rat frontal cortex
37. 18F]altanserin in the human brain
38. In vivo binding of spiperone and N-methylspiperone to dopaminergic and serotonergic sites in the rat brain: Multiple modeling and implications for PET scanning
39. 18F]altanserin
40. 18F]altanserin in human, baboon, and rodent
41. 2A receptors
42. 2A receptors: biodistribution, dosimetry and pharmacokinetics
43. 18F]altanserin
44. 18F]deuteroaltanserin and PET: Feasibility of a constant infusion paradigm